Pharmacy app secures million-pound Royal Mail investment

Charac, an app allowing pharmacies to manage their prescriptions and consultations digitally, has secured a £1 million investment from the Royal Mail Group.

pharmacy investment
Pharmacies can hold consultations via video or phone and manage prescriptions digitally via the app

The £1 million investment will go towards assisting “more local pharmacies and patients across the UK to easily manage their prescriptions and consultations online”, Charac wrote in an announcement yesterday (June 27).

Commenting on the investment, Charac founder Santosh Sahu said: “The pandemic has outlined the necessity of community healthcare and the power of digital delivery.”

“[The] investment will help local pharmacies across the UK adapt, survive and thrive by arming them with the necessary technology to exist in our houses as well as on our high street,” he added.

Meanwhile, Royal Mail health managing director Stefan Kulik – who was recently appointed a board member at Charac – said the prospect of working with the company is “exciting”.

How does the app work?

The app enables independent pharmacies to hold consultations over the phone or via video link and manage prescriptions digitally through what it refers to as its patient relationship management system, which is NHS-approved.

Charac “complements what pharmacists [already] do in our communities”, the company said. By using the app, pharmacists will be able “to focus on providing new, revenue generating […] services” to their local communities, it claimed.

Patients, meanwhile, can use Charac “to manage existing repeat prescriptions, message their pharmacist, schedule future activities such as annual flu vaccinations, and browse the various services on offer from their pharmacy”.

Charac’s aim over the next 12 months is “to sign up over 1,000 UK pharmacies” and to extend “its geographic footprint” beyond cities where it is currently in use, which include London, Manchester, and Birmingham.

In garnering further uptake, the company will target “small multiple and independent pharmacies”, it wrote.

Sign in or register for free

Latest from News

Pharmacies face ‘huge’ losses amid NMS subcontracting ban

 
• By 
 • comment

Small independent pharmacies are facing a financial hit of thousands of pounds per month after reforms banning NMS subcontracting, C+D has learned.

WBA agrees ‘landmark’ $300m settlement over ‘invalid’ scripts

 
• By 
 • comment

Boots’ parent company will pay at least $300m to the US government to “resolve allegations” it filled millions of unlawful opioid and controlled substance prescriptions from 2012 to 2023.

Revealed: Which areas have lost the most pharmacies?

 
• By 
 • comment

New data analysis has revealed the locations of English and Welsh “pharmacy deserts” – the areas worst hit by the more than a thousand pharmacy closures over the last decade.

More from Business